Breaking News

LSNE Passes FDA Inspection

Lyophilization Services of New England, Inc. (LSNE) has recently completed a comprehensive FDA audit of its medical device manufacturing facility in Manchester, NH.

LSNE has recently completed a comprehensive FDA audit of its medical device manufacturing facility in Manchester, NH. The successful completion of the week-long audit, for which no 483 citations were issued, demonstrated a quality cGMP manufacturing environment for services offered.

LSNE also recently completed an FDA Pre-Approval Inspection (PAI) and Compliance Audit for an Abbreviated New Drug Application (ANDA) for a sterile-injectable drug product at its Bedford, NH fill/finish facility.


Click here to learn more about LSNE

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters